SCHEMBL30345337

SCHEMBL30345337

CCCCC1=NCCc2cc(Br)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 2/20 0.39
GLA P06280 1/20 0.39
RCE1 Q9Y256 1/20 0.39
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
LSS P48449 1/20 0.36
SLC2A1 P11166 1/20 0.36
PARP10 Q53GL7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8484264 0.88 CYP1A2 (0.40) NPC1GAANFKB1RAB9ANFKB2
SCHEMBL31173460 0.86 KDM4E (0.41) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10
SCHEMBL5775498 0.79 CYP1A2 (0.41) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10
SCHEMBL25413811 0.78 KDM4E (0.43) GAACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL31107139 0.78 KDM4E (0.43) GAACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL29760451 0.77 CYP1A2 (0.46) GAACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL18183650 0.75 SLC2A1 (0.54) NPC1GAARAB9ACYP1A2CYP3A4
SCHEMBL29757783 0.75 SRD5A1 (0.37) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10
SCHEMBL28811630 0.75 SRD5A1 (0.37) CYP1A2CYP3A4CYP2D6CYP2C19HSD17B10
SCHEMBL28811633 0.74 KDM4E (0.49) KDM4EGLARCE1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4419527-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER Artios Pharma Limited (GB) 2024-08-28 EP disclosed
EP-4416146-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-C] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF Lomond Therapeutics, Inc. (US) 2024-08-21 EP disclosed
WO-2023067355-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2023-04-27 WO disclosed
WO-2023064133-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF LOMOND THERAPEUTICS, INC. (US) 2023-04-20 WO disclosed